|
Inhaled corticosteroids raise pneumonia risk
Science Daily (press release) Sep. 18, 2013 — A University of Alberta researcher says health professionals should be cautious about prescribing inhaled corticosteroids to high-risk patients such as pneumonia survivors, citing a twofold risk for repeat infection. |
Inhaled corticosteroids raise pneumonia riskMedical XpressA University of Alberta researcher says health professionals should be cautious about prescribing inhaled corticosteroids to high-risk patients such as pneumonia survivors, citing a twofold risk…
|
Stomach Cancer Didn’t Respond to Rx
dailyRx This new study — the GRANITE-1 (First Gastric Antitumor Trial With Everolimus) — looked at the efficacy and safety of everolimus in advanced stomach cancer patients whose disease had progressed despite one or two lines of chemotherapy. A total of 656 … |
|
Genetic variations influence everolimus benefit in advanced breast cancer
Healio Women with hormone receptor-positive, HER-2–negative advanced breast cancer who had minimal genetic variations in PI3K, FGFR or CCND1 derived the most benefit from everolimus therapy, according to study results presented at the Breast Cancer … |
Medscape |
Corticosteroids May Counter C difficile Diarrhea
Medscape DENVER — Corticosteroids might reduce the risk for Clostridium difficile–associated diarrhea, report researchers studying patients with chronic obstructive pulmonary disease (COPD) treated with antibiotics. The surprise finding contradicts previous … |
Inhaled corticosteroids increase pneumonia risk in asthmaNews-Medical.netResearch from the UK indicates that the use of inhaled corticosteroids is independently associated with an increased risk for pneumonia and lower respiratory tract infection (LRTI…
OncLiveFirst-Line Standard for Metastatic RCC UpheldOncLiveRobert J. Motzer, MD. The standard of care for metastatic renal cell carcinoma (RCC) prevailed in a randomized comparison of everolimus (Afinitor) and sunitinib (Sutent) as first-line therapy, …
Inhaled corticosteroids increase pneumonia risk in asthmamedwireNewsmedwireNews: Research from the UK indicates that the use of inhaled corticosteroids is independently associated with an increased risk for pneumonia and lower respiratory tract infecti…
|
Combo Therapy Not Superior for Severe Alcoholic Hepatitis
Monthly Prescribing Reference (HealthDay News) – Combination therapy with pentoxifylline and prednisolone, compared with prednisolone alone, does not result in a higher rate of six-month survival in patients with alcoholic hepatitis, according to research published in the Sept. 11 … |
|
Combination Therapy for Severe Alcoholic Hepatitis Does Not Result in …
Science Daily (press release) 10, 2013 — Four weeks of treatment with a combination of the drug pentoxifylline and the corticosteroid prednisolone did not improve 6-month survival compared with prednisolone alone in 270 patients with severe alcoholic hepatitis, according to a … |